Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials
Elisabete Cruz Da Silva, Marie-Cécile Mercier, Nelly Étienne-Selloum, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1795-1795
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial
Alexandre Carpentier, Roger Stupp, Adam M. Sonabend, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 42
Dendritic Cell Vaccination of Glioblastoma: Road to Success or Dead End
Angeliki Datsi, Rüdiger V. Sorg
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 70
New Directions in the Therapy of Glioblastoma
Katarzyna Szklener, Marek Mazurek, Małgorzata Wieteska, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5377-5377
Open Access | Times Cited: 57
Lipid Metabolism in Glioblastoma: From De Novo Synthesis to Storage
Yongjun Kou, Feng Geng, Deliang Guo
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1943-1943
Open Access | Times Cited: 56
Mechanisms of Cell Cycle Arrest and Apoptosis in Glioblastoma
Konstantinos Gousias, Theocharis Theocharous, Matthias Simon
Biomedicines (2022) Vol. 10, Iss. 3, pp. 564-564
Open Access | Times Cited: 52
The influence of the blood–brain barrier in the treatment of brain tumours
Sneha Rathi, Jessica I. Griffith, Wenjuan Zhang, et al.
Journal of Internal Medicine (2022) Vol. 292, Iss. 1, pp. 3-30
Closed Access | Times Cited: 41
Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond
Abdellatif El Khayari, Najat Bouchmaa, Bouchra Taïb, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 39
Glioblastoma Metabolism: Insights and Therapeutic Strategies
Chloé Bernhard, Damien Reita, Sophie Martin, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9137-9137
Open Access | Times Cited: 31
Modern approaches to glioblastoma therapy
Natalya S. Kuznetsova, S. V. Gurova, А. С. Гончарова, et al.
South Russian Journal of Cancer (2023) Vol. 4, Iss. 1, pp. 52-64
Open Access | Times Cited: 24
Revolutionizing Glioblastoma Treatment: A Comprehensive Overview of Modern Therapeutic Approaches
Karol Sadowski, Adrianna Jażdżewska, Jan Kozłowski, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5774-5774
Open Access | Times Cited: 14
Targeted Glioma Therapy—Clinical Trials and Future Directions
A. B. Shikalov, Igor Koman, Natalya M. Kogan
Pharmaceutics (2024) Vol. 16, Iss. 1, pp. 100-100
Open Access | Times Cited: 12
Glioblastoma Stem Cells—Useful Tools in the Battle against Cancer
Silvia Mara Baez Rodriguez, Georgiana-Adeline Staicu, Ani-Simona Sevastre, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4602-4602
Open Access | Times Cited: 30
Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy
Andrew M. Hersh, Hallie Gaitsch, Safwan Alomari, et al.
Cancers (2022) Vol. 14, Iss. 15, pp. 3743-3743
Open Access | Times Cited: 30
Understanding Glioblastoma Signaling, Heterogeneity, Invasiveness, and Drug Delivery Barriers
Nadin Rabah, Fatima-ezzahra Ait Mohand, Nataly Kravchenko‐Balasha
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14256-14256
Open Access | Times Cited: 20
State of the neoadjuvant therapy for glioblastoma multiforme—Where do we stand?
Naeim Nabian, Reza Ghalehtaki, Mehdi Zeinalizadeh, et al.
Neuro-Oncology Advances (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 6
A Drug Screening Pipeline Using 2D and 3D Patient-Derived In Vitro Models for Pre-Clinical Analysis of Therapy Response in Glioblastoma
Sakthi Lenin, Elise Ponthier, Kaitlin G. Scheer, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4322-4322
Open Access | Times Cited: 37
Molecular targeted therapy: A new avenue in glioblastoma treatment (Review)
Oula El Atat, Rayan Naser, Maya Abdelkhalek, et al.
Oncology Letters (2022) Vol. 25, Iss. 2
Open Access | Times Cited: 27
A Custom DNA-Based NGS Panel for the Molecular Characterization of Patients With Diffuse Gliomas: Diagnostic and Therapeutic Applications
Elena Tirrò, Michele Massimino, Giuseppe Broggi, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 26
Nanomedicines Targeting Glioma Stem Cells
Arjun Sabu, Te‐I Liu, Siew Suan Ng, et al.
ACS Applied Materials & Interfaces (2022) Vol. 15, Iss. 1, pp. 158-181
Closed Access | Times Cited: 26
Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era
Augusto Leone, Antonio Colamaria, Nicola Pio Fochi, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1927-1927
Open Access | Times Cited: 24
Efficacy and safety of metformin plus low-dose temozolomide in patients with recurrent or refractory glioblastoma: a randomized, prospective, multicenter, double-blind, controlled, phase 2 trial (KNOG-1501 study)
Wan‐Soo Yoon, Jong Hee Chang, Jeong Hoon Kim, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
It’s all downstream from here: RTK/Raf/MEK/ERK pathway resistance mechanisms in glioblastoma
Rebeca Yakubov, Ramneet Kaloti, Phooja Persaud, et al.
Journal of Neuro-Oncology (2025)
Open Access
Decoding the Role of Kinesin Superfamily Proteins in Glioma Progression
Mohamed J. Saadh, Zahraa Sabah Ghnim, Morug Salih Mahdi, et al.
Journal of Molecular Neuroscience (2025) Vol. 75, Iss. 1
Closed Access
Pharmacological Actions of Myricetin in the Nervous System: A Comprehensive Review of Preclinical Studies in Animals and Cell Models
Jie Li, Haitao Xiang, Chao Huang, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 30
Glioblastoma pharmacotherapy: A multifaceted perspective of conventional and emerging treatments (Review)
Ani-Simona Sevastre, Alexandra Costachi, Ligia Gabriela Tătăranu, et al.
Experimental and Therapeutic Medicine (2021) Vol. 22, Iss. 6
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top